First, we focused on MET, an oncogene that plays a central role in pRCC, especially in the type I. We found rs11762213, a germline exonic single nucleotide polymorphism (SNP) inside MET, predicted cancer-specific survival (CSS) in type II pRCC. This evidence concerns the gene MET and cancer.